Package 43598-358-04

{"route": ["ORAL"], "spl_id": "5e7f1aec-5727-4e71-1a05-55e8eef89e0a", "openfda": {"upc": ["0343598358048"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075", "1918042"], "spl_set_id": ["7eda0d98-c2ba-c117-b757-1f566292e789"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (43598-358-04)", "package_ndc": "43598-358-04", "marketing_start_date": "20200519"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (43598-358-31)  / 10 TABLET in 1 BLISTER PACK (43598-358-79)", "package_ndc": "43598-358-31", "marketing_start_date": "20211220"}], "brand_name": "Abiraterone Acetate", "product_id": "43598-358_5e7f1aec-5727-4e71-1a05-55e8eef89e0a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "43598-358", "generic_name": "Abiraterone Acetate", "labeler_name": "Dr. Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208416", "marketing_category": "ANDA", "marketing_start_date": "20200519", "listing_expiration_date": "20261231"}